I'm sure this quote has been reported before on ECF but since it is relevant to this
thread, I thought I would provide it again and is from our well respected supporter, Dr. Michael Siegel of Boston University:
"In an almost inverse scenario, Michael Siegel a professor in the Department of Community Health Sciences at the Boston University School of Public Health and a well-known e-cigarette advocate, has
accused a fellow professor of failing to disclose his financial ties to "Big Pharma" in a New York Times op/ed, which Siegel says is a conflict of interest. Both professors contributed essays for a
"Room for Debate" editorial feature on whether "electronic cigarettes [are] really helping smokers quit or prolonging nicotine addiction."
Siegel said that Andrew A. Strasser, an associate professor in the department of psychiatry at the University of Pennsylvania's Perelman School of Medicine, and Harold P. Wimmer, the national president and CEO of the American Lung Association denied readers the full story:
It turns out that the author of the commentary has received funding from a company which manufactures a competitive product to electronic cigarettes. Specifically, he has received research funding from Pfizer, the manufacturer of Chantix, a smoking cessation drug that stands to lose substantial sales if electronic cigarettes become increasingly popular. Therefore, this is a significant financial conflict of interest and I think it ought to have been disclosed in the article.
This is not the only commentary which failed to disclose a significant financial conflict of interest. The American Lung Association offered a commentary which urged smokers not to use electronic cigarettes to quit smoking. This is a devastating recommendation that, if followed, will result in increased smoking, disease, and death as thousands of smokers who would otherwise have quit smoking using e-cigarettes will instead continue smoking.
But the larger problem with the commentary is that it fails to disclose a significant financial conflict of interest: the American Lung Association has received millions of dollars of support from Big Pharma; specifically, from Pfizer."